Microtechnology-based in vitro models: Mimicking liver function and pathophysiology

doi:10.1063/5.0061896

Microtechnology-based in vitro models: Mimicking liver function and pathophysiology

2021-10-15

15

OA

AI

DOI：10.1063/5.0061896

Original

Original request for help

Save

Abstract

En 中文

The liver plays important roles in drug metabolism and homeostasis. The metabolism and biotransformation can not only affect the efficacy of drugs but also result in hepatotoxicity and drug-induced liver injury. Understanding the complex physiology of the liver and the pathogenetic mechanisms of liver diseases is essential for drug development. Conventional in vitro models have limitations in the ability to predict drug effects, due to the lack of physiological relevance. Recently, the liver-on-a-chip platform has been developed to reproduce the microarchitecture and in vivo environment of the liver. These efforts have improved the physiological relevance of the liver tissue used in the platform and have demonstrated its applicability to drug screening and disease models. In this review, we summarize the recent development of liver-on-a-chip models that closely mimic the in vivo liver environments and liver diseases.(c) 2021 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license.

Keywords:

ON-A-CHIP

3-DIMENSIONAL CELL-CULTURE

TOTAL BIOASSAY SYSTEM

MICROPHYSIOLOGICAL SYSTEMS

INTESTINAL-ABSORPTION

MICROFLUIDIC PLATFORM

HEPATIC-METABOLISM

ENDOTHELIAL-CELLS

HUMAN HEPATOCYTES

RAT HEPATOCYTES

Microtechnology-based in vitro models: Mimicking liver function and pathophysiology

Abstract

Journal

Organization